Tag: Injective Protocol

Injective Protocol Raises $2.6M For Decentralized Derivatives Exchange Protocol

Prominent Institutional Investors Back Decentralized Cryptocurrency Derivatives Exchange

Injective Protocol, a fully decentralized derivatives exchange protocol, has raised $2.6 million dollars in a seed funding round led by Pantera Capital with participation from world renowned institutional investors including QCP’s investment arm QCP Soteria, Axia8 Ventures, and OK’s strategic investment partner K42.

Injective Protocol aims to solve critical scalability and user experience bottlenecks that trouble decentralized exchanges (DEXs). Beyond providing working capital, the new strategic investors will also provide liquidity solutions for the decentralized exchange as well as support Injective Protocol’s business development and market brand recognition internationally.

Paul Veradittakit, Partner at Pantera Capital, commented on Injective Protocol:

“Injective Protocol scalably brings advanced derivatives capabilities to DeFi while being uncompromisingly decentralized. We see Injective as a strong contender to expand DeFi beyond just Ethereum power users and to serve as an integral layer ushering the new dawn of decentralized derivatives.”

Selected as one of the eight projects to join the Binance Labs Incubation Program in 2018, Injective Protocol has sought to improve the poor liquidity, high latency and lack of compelling product offerings that characterized decentralized exchanges. Today, Injective Protocol’s Layer-2 derivatives exchange protocol provides a fully decentralized, trustless, and front-running resistant exchange protocol that improves the experience of decentralized derivatives trading.

The fresh round of funding arrives in time as the team gears up for mainnet launch and token issuance in the later half of this year.

The disclosed list of investors for the round includes Pantera Capital, QCP Soteria, K42, Axia8 Ventures, Boxone Ventures, Bitlink Capital, BitScale, Krypital Group, The Cabin Capital, and Innovating Capital.

About Injective Protocol

Founded in 2018, Injective Protocol is a fully decentralized, front-running resistant layer-2 decentralized exchange protocol. The protocol is based on the Cosmos-SDK and Ethereum network that integrates a verifiable delay function (VDF) to prevent trade manipulation and front-running. The company was incubated by Binance Labs.

For More Information:
Website: http://www.injectiveprotocol.com
Twitter: https://twitter.com/InjectiveLabs
Medium: http://medium.com/injective-labs/
Telegram: https://t.me/joininjective
Press Contact: contact@injectiveprotocol.com

WOOTRADE Announces Strategic Partnership with Injective Protocol

DeFi Futures Exchange Injective Protocol Works Together with WOOTRADE to Increase DeFi Adoption

Decentralized Exchanges (DEX) are one of the most widely talked about topics in Decentralized Finance (DeFi). It is often considered to be the inevitable next evolution of digital asset exchanges due to addressing the growing problems with centralized exchanges such as the lack of transparency in transactions and frequent loss of assets due to hacking or becoming victims to social engineering.

Injective Protocol is a decentralized layer-2 peer-to-peer protocol that aims to enable fast and secure perpetual swaps, futures, leverage and spot transactions on Ethereum. The partnership will facilitate the transaction by leveraging WOOTRADE’s transaction depth of 100 BTC with a spread of 0.05%. This liquidity stems from the in-depth aggregation of major exchanges, and the support of quantitative investment research institution Kronos Research for market-making strategies. Kronos has a daily transaction volume of $1 billion. In order to provide sufficient liquidity, WOOTRADE will also provide a low rate of 0% for connected exchanges, which saves hedge costs for exchanges. All in all, this collaborative effort will lead to a paradigm shift in the DeFi world.

WOOTRADE was incubated by Kronos Research, a leading quantitative investment research institution, and is funded by distributed capital from DFund, SNZ, Hashkey, as well as vector capital investment. The dark pool has a team that brings extensive experience in trading crypto assets and secondary assets. The top institutional trader has the technical expertise to manage high-level crypto market derivative products. Injective Protocol’s derivatives protocol and technology-driven ecology can provide institutional traders, such as Kronos Research, with the ideal environment and conditions for the fastest, safest and most fair service for its markets and products.

About Injective Protocol

Founded in 2018, Injective Protocol is a fully decentralized, front-running proof layer-2 decentralized exchange. The protocol is based on the Cosmos-SDK and Ethereum network that integrates a verifiable delay function (VDF) to prevent transaction fraud and front-running. Along with early incubation by Binance Labs, they have received support from other top-tier international investment firms.

For More Information:
Website: http://www.injectiveprotocol.com.
Twitter: https://twitter.com/InjectiveLabs
Medium: http://medium.com/injective-labs/
Telegram: https://t.me/joininjective
Press Contact: hello@magicfew.com